Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.
Frequently asked questions
What sector does Helix BioMedix Inc (HXBM) operate in?
Helix BioMedix Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Helix BioMedix Inc (HXBM) current stock price?
As of the latest data, Helix BioMedix Inc stock price is $3.29, with a previous close of $3.29.
What is Helix BioMedix Inc (HXBM) current market capitalization?
Helix BioMedix Inc market cap is approximately 739.29 thousand.
What is Helix BioMedix Inc (HXBM) Earnings Per Share (EPS)?
The trailing EPS is -$1.65.
Does Helix BioMedix Inc (HXBM) pay dividends?
No. Helix BioMedix Inc does not pay a dividend.
What is Helix BioMedix Inc (HXBM) beta (volatility) score?
Helix BioMedix Inc has a beta of 1.752, suggesting it is more volatile than the market.